Bismuth Sulfide Nanorods with Retractable Zinc Protoporphyrin Molecules for Suppressing Innate Antioxidant Defense System and Strengthening Phototherapeutic Effects
Source abstract
Abstract
Abstract Bismuth (Bi)‐based nanomaterials (NMs) are widely used for computed tomography (CT) imaging guided photothermal therapy, however, the photodynamic property is hardly exhibited by these NMs due to the fast electron–hole recombination within their narrow bandgap. Herein, a sophisticated nanosystem is designed to endow bismuth sulfide (Bi2S3) nanorods (NRs) with potent photodynamic property. Zinc protoporphyrin IX (ZP) is linked to Bi2S3 NRs through a thermoresponsive polymer to form BPZP nanosystems. The stretching ZP could prebind to the active site of heme oxygenase‐1 overexpressed in cancer cells, suppressing the cellular antioxidant defense capability. Upon NIR laser irradiation, the heat released from Bi2S3 NRs could retract the polymer and drive ZP to the proximity of Bi2S3 NRs, facilitating an efficient electron–hole separation in ZP and Bi2S3 NRs, and leading to reactive oxygen species generation. In vitro and in vivo studies demonstrate the promising photodynamic property of BPZP, together with their photothermal and CT imaging performance.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Heme Oxygenase-1 and Carbon Monoxide
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Laboratory of Chemical Biology Changchun Institute of Applied Chemistry Chinese Academy of Sciences Changchun 130022 Jilin China
University of Chinese Academy of Sciences Beijing 100039 China
University of Science and Technology of China Hefei 230026 Anhui China
Funding
National Natural Science Foundation of China · Chinese Academy of Sciences
References (26)
Show source-provided references
1. 10.1038/nmat157110.1038/nmat1571 ↗
2. 10.1002/adma.20110328910.1002/adma.201103289 ↗
3. 10.1021/nn506137n10.1021/nn506137n ↗
4. 10.1002/adma.20170413610.1002/adma.201704136 ↗
5. 10.1039/C6NR03398A10.1039/C6NR03398A ↗
6. 10.1038/srep0199810.1038/srep01998 ↗
7. 10.1002/adma.20140425710.1002/adma.201404257 ↗
8. 10.1021/acsnano.7b0047610.1021/acsnano.7b00476 ↗
9. 10.1023/B:APPT.0000012119.83734.4e10.1023/B:APPT.0000012119.83734.4e ↗
10. 10.1038/sj.bjc.660083010.1038/sj.bjc.6600830 ↗
11. 10.1152/physrev.00011.200510.1152/physrev.00011.2005 ↗
12. Fang J. · Cancer Res. · 2003 · 63 · 3567
13. 10.1002/ijc.2228710.1002/ijc.22287 ↗
14. 10.1182/blood.V97.5.130610.1182/blood.V97.5.1306 ↗
15. 10.2174/092986731132030000310.2174/0929867311320300003 ↗
16. 10.1002/smll.20160393510.1002/smll.201603935 ↗
17. 10.1155/2010/54713510.1155/2010/547135 ↗
18. 10.1039/C4RA15798B10.1039/C4RA15798B ↗
19. 10.1039/C6RA01488G10.1039/C6RA01488G ↗
20. 10.1039/C4TA00696H10.1039/C4TA00696H ↗
21. 10.1002/adfm.20140163610.1002/adfm.201401636 ↗
22. 10.1016/j.biomaterials.2013.07.01410.1016/j.biomaterials.2013.07.014 ↗
23. 10.1126/science.111439710.1126/science.1114397 ↗
24. 10.1021/ja501699e10.1021/ja501699e ↗
25. 10.1161/CIRCULATIONAHA.105.59869810.1161/CIRCULATIONAHA.105.598698 ↗
26. Cheng Y. · Small · 2017 · 13